Reg. 43.3- 901.e Registration of a Primary Center A Center licensed pursuant to section 12-43.3-402 C.R.S.

, shall not allow a patient to register the Center as a Primary Center if the patient has designated another Center as its Primary Center and any plants in possession of the former Primary Center have not yet matured and been cultivated and harvested.

1

70/30 Rule Proposal (1) During the hours established in section 12-43.3-901 (4) (l), medical marijuana manufactured by a medical marijuana center licensee with an optional cultivation premises license may be: (a) Distributed to medical marijuana center or marijuana infused product manufacturers licensees. Only medical marijuana manufactured and packaged on the optional cultivation premises by the licensee shall be distributed from the licensed premise in labeled and tamper proof sealed packages in accordance with Regulation 43- _______ “Distribution”; (b) Sold at wholesale to medical marijuana center licensees. A medical marijuana center may sell no more than thirty percent, per calendar year, of its total cumulative on-hand medical marijuana inventory, as defined by Regulation 43.3-402 “Inventory” per calendar year to another medical marijuana center licensee. A medical marijuana center licensee may purchase at wholesale an amount up to thirty percent, per calendar year, of its total cumulative on-hand medical marijuana inventory as defined by Regulation 43.3-402, “Inventory.” (c) Distributed and/or sold at wholesale to marijuana infused product manufacturer licensees utilizing an approved contract as provided by section 1243.3-402 (2) (b). For purposes of determining compliance with subsection (b) herein, medical marijuana distributed or sold to a marijuana infused products licensee by a medical marijuana center licensee shall not be included. (d) Exchanged in equal weights measured by common weights and measures, by and between, medical marijuana center licensees. For purposes of determining compliance with subsection (b) herein, medical marijuana exchanged by medical marijuana center licensees shall not be included. (2) All medical marijuana distributed in accordance with paragraph (1) and shall be accounted for in accordance with the Medical Marijuana Code and all promulgated rules including, but not limited to, Regulation 43-_______ “Distribution” and Regulation 43-________ “Sale”. A medical marijuana center licensee shall verify the license status of a medical marijuana center or marijuana infused products licensee prior completing a transaction. (3) Records maintained by the licensee in compliance with 12-43.3-701, C.R.S., shall include all records of purchases and exchanges of medical marijuana. (4) Any medical marijuana purchased or received from a licensee pursuant to this regulation must be medical marijuana which the licensee is authorized to sell, exchange and/or possess as provided by the Colorado Medical Marijuana Code. (5) A medical marijuana center licensee shall notify the State Licensing Authority within two business days of any catastrophic event which should require the State Licensing Authority to consider a mitigation plan in relation to this regulation.

2

Statement of Authority, Basis, Purpose, and Fiscal Impact of Proposed Regulation 1 CCR 212 Regulation 43.3-____. ____________________ Statutory Authority: §12-43.3-201 and §12-43.3-202 (House Bill 10-1284) which became effective on July 01, 2010 Basis and Purpose: To comply with the requirements of House Bill 10-1284 which requires the State Medical Marijuana Licensing Authority to promulgate rules necessary for the proper regulation and control of the cultivation, manufacture, distribution, and sale of medical marijuana and the enforcement of Article 43.3 of Title 12, C.R.S. In addition, §12-43.3202(1)(b)(I) requires the state licensing authority to ensure the regulation of the cultivation, manufacture, distribution and sale of medical marijuana. Further, §12-43.3-202(2)(a)(VI) requires the state licensing authority to establish rules prohibiting misrepresentation and unfair practices, and §12-43.3-202(2)(a)(VII) requires the state licensing authority to establish rules controlling informational and product displays on licensed premises. During the period of August 27, 2010 through December 31, 2010, the Medical Marijuana Enforcement Division consulted with interested parties from the medical marijuana industry, the legal profession and local and state government to draft the proposed rules and ensure adequate oversight and regulation of the medical marijuana industry. Fiscal Impact: This revision has no fiscal impact.

3

Regulation 43.3 - __1___Medical Marijuana Center Sales (A) Advertising Practices. 1. No Medical Marijuana Center licensee shall display upon or in proximity to, or referring to the licensed premises, use, publish or exhibit, or permit to be used, published, any sign, advertisement, display, notice, symbol or other device which are inconsistent with the local laws and regulations in which the licensee operates. 2. No Medical Marijuana Center licensee shall display upon or in proximity to, or referring to the licensed premises, use, publish or exhibit, or permit to be used, published, any sign, advertisement, display, notice, symbol or other device which uses misleading, deceptive, or false advertising. The use of misleading, deceptive, and/or false advertising shall be grounds for administrative sanction by the State Licensing Authority. 3. No Medical Marijuana Center licensee shall display upon or in proximity to, or referring to the licensed premises, use, publish or exhibit, or permit to be used, published, any sign, advertisement, display, notice, symbol or other device which uses advertising that is designed to appeal to minors. The use of advertising that is designed to appeal to minors by a licensee shall be grounds for administrative sanction by the State Licensing Authority. (B) Identification and Labeling 1. No Medical Marijuana Center licensee shall sell, offer, expose for sale, or distribute any medical marijuana unless such medical marijuana is labeled so as to clearly indicate a list of all chemical additives, including but not limited to non-organic pesticides, herbicides, and fertilizers that were used in the cultivation and production of the medical marijuana. 2. No Medical Marijuana Center licensee shall sell, offer, expose for sale, or distribute any medical marijuana infused products unless such medical marijuana infused products are labeled so as to clearly indicate (i) that the product contains medical marijuana (ii) that the product is manufactured without any regulatory oversight for health, safety, or efficacy; and (iii) that there may be health risks associated with the consumption or use of the product. (C) Patient Sales 1. No Medical Marijuana Center licensee shall sell, offer, expose for sale, or distribute any medical marijuana to a Colorado medical marijuana registered patient, unless prior to initiating the sale on the licensed premises, the licensee verifies that the purchaser has a valid registration card pursuant to section 25-1.5-106, C.R.S., and a valid picture identification that matches the name on the registration card. 2. If a licensee or a licensee’s employee has reasonable cause to believe that a person is exhibiting a fraudulent patient registry 4

identification card in an attempt to obtain medical marijuana, the licensee or employee shall be authorized to confiscate the fraudulent patient registry identification card, if possible, and shall within seventytwo hours turn it over to the State Health Department. 3. All medical marijuana sold, offered, or otherwise distributed by licensees to Colorado medical marijuana registered patients shall be weighed, logged, and recorded. Books and records necessary to show fully the business transactions of the licensee shall be retained for a period of the current tax year and three immediately prior tax years. 4. All medical marijuana sold, offered, exposed for sale or otherwise distributed by licensees to Colorado medical marijuana registered patients shall be only such medical marijuana cultivated, manufactured, or otherwise lawfully acquired as set forth by the Colorado Medical Marijuana Code. (D) Wholesale Sales 1. No Medical Marijuana Center licensee shall sell, offer, expose for sale, or distribute for wholesale any medical marijuana, unless prior to initiating the sale on a licensed premises, the licensee verifies that the wholesale purchaser is a licensee in good standing with the State Licensing Authority. 2. If a licensee or a licensee’s employee has reasonable cause to believe that the wholesale purchaser is exhibiting fraudulent documentation in order to purchase medical marijuana, the licensee or employee shall be authorized to confiscate the fraudulent documentation, if possible, and shall within seventy-two hours notify the State Licensing Authority and/or local law enforcement. 3. All medical marijuana sold, offered, or otherwise distributed for wholesale by and between licensees shall be weighed, logged, and recorded. Books and records necessary to show fully the business transactions of the licensee shall be retained for a period of the current tax year and three immediately prior tax years. 4. All licensees purchasing or otherwise lawfully acquiring medical marijuana for retail sale shall promptly weigh, log and record the medical marijuana as provided by Regulation 43.3-402 Inventory; and pay any and all tax due on such products pursuant to 12-43.3-401(2) C.R.S. 5. All medical marijuana sold, offered, exposed for sale or otherwise distributed by and between licensees shall be only such medical marijuana cultivated, manufactured, or otherwise lawfully acquired as set forth by the Colorado Medical Marijuana Code.

5

Statement of Authority, Basis, Purpose, and Fiscal Impact of Proposed Regulation 1 CCR 212 Regulation 43.3-____. ____________________ Statutory Authority: §12-43.3-201 and §12-43.3-202 (House Bill 10-1284) which became effective on July 01, 2010 Basis and Purpose: To comply with the requirements of House Bill 10-1284 which requires the State Medical Marijuana Licensing Authority to promulgate rules necessary for the proper regulation and control of the cultivation, manufacture, distribution, and sale of medical marijuana and the enforcement of Article 43.3 of Title 12, C.R.S. In addition, §12-43.3202(1)(b)(I) requires the state licensing authority to ensure the regulation of the cultivation, manufacture, distribution and sale of medical marijuana. During the period of August 27, 2010 through December 31, 2010, the Medical Marijuana Enforcement Division consulted with interested parties from the medical marijuana industry, the legal profession and local and state government to draft the proposed rules and ensure adequate oversight and regulation of the medical marijuana industry. Fiscal Impact:
This revision has no fiscal impact.

6

Regulation 43.3 – 402 Inventory (1) “Inventory”, shall be measured by common weights and measures and consist of both plant count within a licensees Optional Premises Cultivation Premises which shall not exceed 6 plants per primary center patient; and the total processed weight of all processed cannabis, such as but not limited to, flowers, kief, leaf, shake, MARIJUANA CLONES PLACED IN A GROWING MEDIUM, and processed concentrates and oils not subject to §12-43.3-104 (9) located on the licensed premises of a medical marijuana center, not to exceed two ounces per primary center patient. (2) Notwithstanding the requirements of subsection (1) of this section to the contrary, a licensee may, in the case of a patient authorized to possess more than 6 plants and two ounces, possess such additional medical marijuana as provided by §12-43.3-901(4)(e). 3) INVENTORY DETERMINATION: (a) All plants of the genus cannabis, INCLUDING MARIJUANA CLONES PLACED IN A GROWING MEDIUM, in possession of a licensee while at an optional premises cultivation facility shall be considered plant inventory. (b) Propagation includes but is not limited to the reproduction of cannabis plants by seeds, cuttings or grafting in a designated limited access area ONLY of an optional premises cultivation facility that is monitored by one or more surveillance cameras as required by rule. The propagation space shall be clearly identified by signage designated by the state licensing authority and all marijuana located in the propagation space shall be accounted for. Propagation shall only be allowed upon an OPCL licensed premises. (c) Vegetation is the sporophytic state of the cannabis plant which is a form of asexual reproduction in plants during which plants do not produce resin or flowers and are bulking up to a desired production size for flowering in a designated limited access area monitored by one or more surveillance cameras as provided in rule. The vegetation space shall be clearly identified by signage designated by the state licensing authority and all marijuana located in the vegetation space within a limited access area of an optional premises cultivation facility shall be accounted for. Vegetation may only occur within a limited access area upon the licensed premises of an optional premises cultivation facility. (d) Flowering is the gametophytic or reproductive state of cannabis in which the plant is in a designated flowering space that is a limited access area monitored by one or more surveillance cameras within an optional premises cultivation facility with a light cycle intended to produce flowers, trichromes and cannabinoids characteristic of medical marijuana. The flowering space shall be clearly identified by signage designated by the state licensing authority and all

7

marijuana shall be accounted for. Flowering plants may only be possession within a limited access area of a licensed optional premises cultivation facility. (e) Throughout the propagation and vegetation phases, an optional premises cultivation licensee shall tag and maintain a true and accurate accounting of all non-flowering cannabis plants including those destroyed or transferred to the MMC for sale. All accounting reports shall be made available to the state licensing authority, or other local authority, on demand. (4) Once harvested, tagged medical marijuana plants shall be combined in batches for tracking through the entire manufacturing process with the tags for each medical marijuana plant accompanying each batch at each stage of manufacture. Each batch will be identified by listing the identifying markers from the individual plants from the designated flowering area and a data collection point will occur in which the batch will be weighed, duly recorded and clearly identified within sight of a video camera and the “wet” weight of buds, stems and leaf duly recorded as unprocessed product, wholesale byproduct, and waste. The identifying markers associated with each batch shall be prominently displayed on drying racks or wires and curing containers throughout the manufacturing process. (5) “Processed” as used in this rule shall mean the final dried, finished and useable marijuana product having been sifted and sorted to remove plant waste stems, and/or seeds and other byproducts to be prepared for final packaging and transport to the licensed center as permitted in law. (6) Prior to packaging, the processed medical marijuana plants shall be weighed before transfer to the MMC or MIPs, and the weight of unfinished product, wholesale byproduct and waste as a data collection point recorded. Processed marijuana shall be immediately packaged, sealed, weighed and stored in an approved secure transportation container for transport to the licensed premises of the MMC. Medical marijuana packaging shall be in sealed containers/packaging with tamper-proof bands. (tagged, bar coded, RFID options) (7) All medical marijuana shall be weighed in a limited access area of an optional premises cultivation facility monitored by one or more cameras before and after packaging to determine product weight and total package weight and tagged with both weights before being transported to the MMC. (8)(a)For inventory purposes, all inventory processed and stored in an approved secure transportation container shall be accounted for as inventory of the MMC. (9) Processed medical marijuana plants shall be packaged in units of one pound or less and tagged with the total weight of the packaged product and securely

8

sealed in a tamper-proof manner. The packages will be transported to the MMC within ____ hours/days and recorded as inventory at the receiving MMC. (10) Packaged medical marijuana shall be weighed, logged out, and transported directly from the optional premises cultivation facility to the medical marijuana center’s licensed premises in a secure fashion and out of plain sight. (11) Transport will be made by an individual licensed by the state licensing authority and as authorized pursuant to Reg 43.3-______________. (12) On arrival at the licensed center, all packages containing medical marijuana shall immediately be re-weighed in a limited access area of the MMC and monitored by one or more cameras and logged in to the licensed Center’s inventory. (tags, bar codes, RFID?) (13) If medical marijuana product is intended for wholesale distribution to another licensed medical marijuana Center licensed premises, it shall be weighed in a limited access area of the center and monitored by one or more cameras as provided in rule and logged out of the originating center for pickup and transport to the receiving licensed center or infused products manufacturer as authorized by law. Second Version 11/16/10 Regulation 43.3 – 402 Inventory (1) “Inventory”, shall be measured by common weights and measures and consist of both: a) plant count within a licencee’s OPC and MMC which shall not exceed 6 plants per patient designated to the MMC including marijuana clones placed in a growing medium; and b) the total weight of all packaged cannabis such as but not limited to flowers, kief, leaf, shake, concentrates and oils not subject to §12-43.3-104 (9) located on the licensed premises of a medical marijuana center, not to exceed two ounces per primary center patient. (2) Notwithstanding the requirements of subsection (1) of this section to the contrary, a licensee may, in the case of a patient authorized to possess more than 6 plants and two ounces, possess such additional medical marijuana as provided by §12-43.3-901(4)(e). 3) INVENTORY DETERMINATION: (a) All plants of the genus cannabis, INCLUDING MARIJUANA CLONES PLACED IN A GROWING MEDIUM, in possession of a licensee while at an optional premises cultivation facility shall be considered plant inventory.

9

(b) Propagation includes but is not limited to the reproduction of cannabis plants by seeds, cuttings or grafting in a designated limited access area ONLY of an optional premises cultivation facility that is monitored by one or more surveillance cameras as required by rule. The propagation space shall be clearly identified by signage designated by the state licensing authority and all marijuana located in the propagation space shall be accounted for. Propagation shall only be allowed upon an OPCL licensed premises. (c) Vegetation is the sporophytic state of the cannabis plant which is a form of asexual reproduction in plants during which plants do not produce resin or flowers and are bulking up to a desired production size for flowering in a designated limited access area monitored by one or more surveillance cameras as provided in rule. The vegetation space shall be clearly identified by signage designated by the state licensing authority and all marijuana located in the vegetation space within a limited access area of an optional premises cultivation facility shall be accounted for. Vegetation may only occur within a limited access area upon the licensed premises of an optional premises cultivation facility. (d) Flowering is the gametophytic or reproductive state of cannabis in which the plant is in a designated flowering space that is a limited access area monitored by one or more surveillance cameras within an optional premises cultivation facility with a light cycle intended to produce flowers, trichromes and cannabinoids characteristic of medical marijuana. The flowering space shall be clearly identified by signage designated by the state licensing authority and all marijuana shall be accounted for. Flowering plants may only be possession within a limited access area of a licensed optional premises cultivation facility. (e) Throughout the propagation and vegetation phases, an optional premises cultivation licensee shall tag and maintain a true and accurate accounting of all non-flowering cannabis plants including those destroyed or transferred to the MMC for sale. All accounting reports shall be made available to the state licensing authority, or other local authority, on demand. (4) Once harvested, tagged medical marijuana plants shall be combined in batches for tracking through the entire manufacturing process with the tags for each medical marijuana plant accompanying each batch at each stage of manufacture. Each batch will be identified by listing the identifying markers from the individual plants from the designated flowering area and a data collection point will occur in which the batch will be weighed, duly recorded and clearly identified within sight of a video camera and the “wet” weight of buds, stems and leaf duly recorded as unprocessed product, wholesale byproduct, and waste. The identifying markers associated with each batch shall be prominently displayed on drying racks or wires and curing containers throughout the manufacturing process.

10

(5) “Processed” as used in this rule shall mean the final dried, finished and useable marijuana product having been sifted and sorted to remove plant waste stems, and/or seeds and other byproducts to be prepared for final packaging and transport to the licensed center as permitted in law. (6) Prior to packaging, the processed medical marijuana plants shall be weighed before transfer to the MMC or MIPs, and the weight of unfinished product, wholesale byproduct and waste as a data collection point recorded. Processed marijuana shall be immediately packaged, sealed, weighed and stored in an approved secure transportation container for transport to the licensed premises of the MMC. Medical marijuana packaging shall be in sealed containers/packaging with tamper-proof bands. (tagged, bar coded, RFID options) (7) All medical marijuana shall be weighed in a limited access area of an optional premises cultivation facility monitored by one or more cameras before and after packaging to determine product weight and total package weight and tagged with both weights before being transported to the MMC. (8)(a)For inventory purposes, all inventory packaged and stored in an approved secure transportation container shall be accounted for as inventory of the MMC. (9) Processed medical marijuana plants shall be packaged in units of one pound or less and tagged with the total weight of the packaged product and securely sealed in a tamper-proof manner. The packages will be transported to the MMC within 48 hours/days and recorded as inventory at the receiving MMC. (10) Packaged medical marijuana shall be weighed, logged out, and transported directly from the optional premises cultivation facility to the medical marijuana center’s licensed premises in a secure fashion and out of plain sight. (11) Transport will be made by an individual licensed by the state licensing authority and as authorized pursuant to Reg 43.3-______________. (12) On arrival at the licensed center, all packages containing medical marijuana shall immediately be re-weighed in a limited access area of the MMC and monitored by one or more cameras and logged in to the licensed Center’s on hand inventory. (tags, bar codes, RFID?) (13) If medical marijuana product is intended for wholesale distribution to another licensed medical marijuana Center licensed premises, it shall be weighed in a limited access area of the center and monitored by one or more cameras as provided in rule and logged out of the originating center for pickup and transport to the receiving licensed center or infused products manufacturer as authorized by law.

11

Regulation 43.3-904. Product Labeling, Substitution, Sampling and Analysis. A. No licensee, for the sale of medical marijuana shall sell, transfer or give away any medical marijuana that does not contain a label with a list of all chemical additives, including but not limited to nonorganic pesticides, herbicides, and fertilizers that were used in its cultivation and production. B. In addition, all labels shall include: (1) the license number of the optional premises cultivation licensee, the medical marijuana center if medical marijuana was obtained from a center not licensed the same as the optional premises cultivation facility, or if being sold by a different licensed medical marijuana center, that Center’s license number; (2) the date of sale; (3); and (4) the patient registry number of the purchaser. All “edibles” shall also contain the following statement: “This product is infused with medical marijuana and was produced without regulatory oversight for health, safety or efficacy and there may be health risks associated with the consumption of the product.” C. All licensees for the sale of medical marijuana shall, upon request of the MMED or any of its officers, make available to the person so requesting a sufficient quantity of such medical marijuana to enable laboratory or chemical analysis thereof. The licensee shall be notified of the results of the analysis without delay. D. The Director of the Medical Marijuana Enforcement Division may contract with a laboratory to conduct independent testing of Medical Marijuana products. Testing may be conducted for determining if samples of medical marijuana contain molds, pesticides or other substances that may be present. To ensure integrity such testing shall be conducted by a laboratory that does not process samples for any licensee.

12

MEDICAL MARIJUANA-INFUSED PRODUCTS LABELING. 43.3-xxx Label Requirements. A. All medical marijuana-infused products which are sold, offered for sale or exposed for sale, or transported within the State of Colorado for sale shall bear thereon or have attached thereto in a conspicuous place a plainly written or printed label or tag in the English language, giving the following information, which statement shall not be modified or denied in the labeling or on another label attached to the product: 1. an identity statement; 2. a net weight statement; 3. a list of ingredients; 4. expiration date information; 5. batch tracking information; 6. basic medical and/or legal warning information; and 7. statement of the company name and state licensing authority registration number, together with the company’s telephone number or mailing address or website information; B. The minimum print size for each of the four required statements is 1/16 inch. The size of the characters in the net weight statement is determined by the area of the principal display panel (see items 6 and 7 under Net Weight or Net Contents) and may be greater than 1/16 inch. C. The product identity and net weight statements must appear on the portion of the label displayed to the consumer. D. When a medical marijuana-infused product is made specifically for a designated patient, the label of that product shall state the patient’s Medical Marijuana Registry number. D. The list of ingredients and company name statements must be conspicuously listed on the medical marijuana-infused product package. E. A nutrition facts panel may be required if nutritional claims are made on the label. 43.3-xxx Identity Statement – Defined. Identity is the common name of the medical marijuana-infused product, or an appropriate descriptive term. A fanciful name commonly used by the public is acceptable when the nature of the medical marijuana-infused product is obvious. Any name may be used as long as it is qualified by a descriptive name of what the product actually is. Brand names, trademarks, or product identities that are

13

misleading will not be allowed (e.g. organic medical marijuana-infused product, when the product is not organic). 43.3-xxx Net Weight or Net Contents Statement - Defined. A. The net contents are listed in either ounces, pounds, fluid ounces, pints and/or quarts depending on the consistency of the product and common practice. B. The net weight statement shall have the words Net Weight, or Net Wt. for medical marijuana products sold by weight. The terms Fl. oz., or Net_fl. Oz. or Net Contents_fl. oz. shall be used for medical marijuana-infused products sold by fluid measure. C. It is highly recommended that a metric equivalent be included as a parenthetical statement in the net weight statement (e.g. Net Wt. 1lb. (454 g.) or 1 pt. (473 ml) or net 1 fl. oz. (29.5 ml)). D. Medical weight information shall be listed, including basic calculation of medical weight of medical marijuana and what type of infusion it is contained within, i.e., product is made with .5 grams of medical marijuana in an infusion of glycerin, product is made with .3 grams medical marijuana in an infusion of has made exclusively with cannabis flowers, product is made with 1.1 grams medical marijuana in an infusion of butter made with whole plant material, etc. E. The net weight statement must be parallel to the base of the package and shall be in the lower 30% of the label. F. An empty space void of printing must be maintained between any printed matter appearing above, below, to the left, or the right of the net weight statement. The empty space above and below the net weight statement shall be equal to the height of the characters in the net weight statement. The empty space to the left and the right of the net weight statement shall be equal to twice the width of the letter “N” used in the style of printing in the net weight statement. G. The size of the characters in the net weight statement is determined by the area of the surface or side of the food package on which the label is displayed. This surface or side is called “the area of the principal display panel.” The following information should b e used to determine the area of the principal display panel: 1. For rectangular packages, multiply the length of the package by the width of the package. 2. For cylindrical or nearly cylindrical containers, multiply 40% of the height of the container by the circumference of the container.

14

3. Determine 40% of the surface area for containers with an otherwise different shape. H. All numbers and letters (including the “e” in net) shall have the minimum heights indicated by the table below: Label area of the package surface 5 square inches or less More than 5 square inches but not more than 25 square inches More than 25 square inches but not more than 100 square inches Greater than 100 square inches 43.3-xxx List of Ingredients – Defined. A. Medical marijuana ingredients including medical marijuana extracts and/or infusions and any other ingredient contained in the medical marijuanainfused product shall be listed in decreasing order of volume from most to least. The ingredient present in the greatest quantity is listed first and the least is listed last. B. All of the medical marijuana ingredients must be listed by their common or usual name. Other ingredients must be identified by their common name or usual name. C. Major allergens, including but not limited to milk, eggs, fish crustacean shellfish, tree nuts, wheat, peanuts, and soybeans must be declared in one of two ways: 1. Label with statement “Contains [allergen source]” immediately after or adjacent to the list of ingredients in a type size no smaller than the type size used in the list of ingredients (e.g. “Contains peanuts”); or 2. Include the allergen source name in parentheses in the list of ingredients immediately after the ingredient (e.g. “Casein (Milk).” D. All manufacturers of medical marijuana-infused products shall maintain detailed and accurate records of all ingredients and components used in the production of medical marijuana-infused products. 43.3-xxx Expiration Date Information. A. Definitions: Size of net wt. Characters 1/16” min. height 1/8” min. height 3/16” min. height ¼” min. height

15

1. As used in these rules, unless the context otherwise requires: a. Perishable product means any medical marijuana-infused product having a significant risk of spoilage, loss of medicinal value, loss of palatability, or loss of viscosity within 60 days of the date of packaging. b. Semi-perishable product means any medical marijuana-infused product for which a significant risk of spoilage, loss of medicinal value, loss of palatability, or loss of viscosity occurs only after a minimum of 60 days, but within 6 months, after the date of packaging. c. Long shelf-life product means any medical marijuana-infused product for which a significant risk of spoilage, loss of medicinal value, loss of palatability, or loss of viscosity does not occur sooner than 6 months after the date of packaging including, but not limited to, medical marijuana-infused products preserved by freezing, dehydrating, being placed in a hermetically sealed container, or incorporated into a topical preparation. d. “Sell by” date means a recommended last date of sale that permits a subsequent period before deterioration of qualities described by perishable product, semi-perishable product and long shelf-life product described above. A “sell by” date refers to best quality and is not a safety date. e. Prepackaged means packaged prior to being displayed or offered for sale. B. Sale of medical marijuana-infused product and date determination. 1. A medical marijuana-infused product shall not be sold or offered for sale unless it is identified with a “sell by” date as defined hereunder. 2. Medical marijuana-infused products shall not be offered for sale after the “sell by” date unless it is wholesome and advertised in a conspicuous manner as being offered for sale after the recommended last date of sale. The placement of a sign, sticker, or tag by the retailer or final seller on the product is acceptable for such advertising if it is easily readable and clearly identifies the medical marijuana-infused product offered for sale after the recommended last date of sale. 3. A manufacturer, processor, packer, repacker, retailer, or other person who prepackages medical marijuana-infused products shall determine a date that allows a reasonable period after sale for use or consumption of the medical marijuana-infused product without physical spoilage, loss of value, loss of palatability, or loss of viscosity. A reasonable period for use or consumption shall consist of at least one third of the approximate total shelf life of the perishable food.

16

a. In determining the “sell by” date, a manufacturer, processor, packer, repacker, retailer, or other person shall take into consideration the medical marijuana quality, characteristics, formulation, processing impact, packaging or container and other wrapping or coating, customary transportation, and storage and display conditions. For purposes of calculating this date, home storage conditions shall be considered to be similar to those in the usual retail store except that the date for refrigerated medical marijuana-infused products may be calculated by using a home storage temperature standard of 40°F (4.4°C). 4. A retailer who purchases prepackaged medical marijuana-infused product(s) may upon written agreement with the person prepackaging such product determine, identify, and be responsible for the “sell by” date placed on or attached to each package of such product. 5. The “sell by” date shall be displayed with the term “sell by” or words of similar import immediately preceding or immediately over the designated date unless a prominent notice is on the label describing the date as a “sell by” date and indicating the location of the date. 6. The “sell by” date shall be designated by: a. the first three letters of the month, preceded or followed by a numeral indicating the calendar day, and the year expressed as a two or four digit number; or b. the month represented numerically followed by a numeral designation of the calendar day, and the year expressed as a two or four digit number 7. A manufacturer, processor, packer, repacker, retailer, or other person responsible for establishing the “sell by” date for medical marijuana-infused products shall keep a record of the method used for the determination of that date. A record revision is necessary whenever a factor affecting date determination is altered. Such record shall be retained for not less than six (6) months after the most recent “sell by” date and be available for examination upon request by the state licensing authority. 43.3-xxx Batch tracking information. Standards not yet developed. 43.3-xxx Basic medical and/or legal warning information. At a minimum, the label of any medical marijuana-infused product shall inform patients that the product may affect each individual differently, and that the

17

patient should consult their caregiver or physician if they have any questions or for additional information. 43.3-xxx Statement of Company Identification and Contact Information. A. The name and state licensing authority registration number of the manufacturer, packer or distributor of the medical marijuana-infused product must be listed on the product’s label. B. The manufacturer, packer or distributor of the medical marijuanainfused product can decide whether to list either it’s phone number, mailing address or website information on the label, but must list at least one of these three designated contact sources on the product’s label. C. If the firm listed on the label does not manufacture the medical marijuana-infused product, then the relation between the firm and the product must be declared with a term such as “Distributed by” or “Packed by” or “Manufactured for.” 43.3-xxx Patient information. Patient confidentiality shall be preserved. Accordingly, the Medical Marijuana Registry number provided on the patient registration card shall be used on the product label or the product information sheet to identify the patient to whom a product is sold, rather than the patient’s name. 43.3-xxx Claims made in labeling must be able to be verified. A. Any labeling statements or claims must be capable of verification using acceptable test procedures and analytical techniques, i.e. if a medical marijuanainfused products manufacturer claims a product is a certain quantity of “X,” the manufacturer must be able to show a comparable amount of multiplied medicine to support the claim. Example: a patient buying a 2X item with 3 grams of extract would expect to find 6 grams of extract in a 4X same item from the same manufacturer. 1. If a medical marijuana-infused products manufacturer includes a claim from a forensic science laboratory or another testing facility on the label of their product(s), the manufacturer must also include conspicuously on the label a disclaimer indicating that potency testing is not 100% accurate; and 2. the medical marijuana-infused products manufacturer who includes a claim from a forensic science laboratory or another testing facility on the label of their product(s) must also include the date(s) on which such tests have been performed.

18

43.3-xxx Laboratory analysis. The amount of material to test shall be that required to carry out the specific test(s) needed without specifying a particular volume or weight. 43.3-xxx Special considerations. A. Preparation of hashish. Because extraction of cannabis oil using volatile liquids such as butane or hexane are dangerous, this type of activity shall be confined to only those medical marijuana-infused products manufacturers who have met all standards set forth under the medical marijuana laws and these rules concerning ventilation and extraction hoods. No butane or other combustible residual media remain in the product. All materials used in the extraction of oils by volatile liquids shall be laboratory quality metal and/or glass. Plastic pipe such as PVC shall be prohibited for use in extracting oils with volatile liquids. B. Preparation of “bubble hash.” Only food-grade equipment shall be used in the production of hashish using ice or water extraction. Appropriate standards of cleanliness [food handling?] shall apply to areas of optional premises cultivation operations or medical marijuana centers used for production of such concentrates, and proper procedures for the cleaning of equipment used in their preparation shall be followed.

19

43.3-xxx Organic Program. A. Organic – Defined. 1. As used in these rules, unless the context otherwise requires, crops may be described or designated as “organic” if all growing media, including soil and hydroponic solutions, as well as all pesticides, herbicides and additives including fertilizers used in or on a crop of cannabis plants intended for human use have been designated as “organic” by an organization such as the Organic Materials Review Institute (OMRI) or another recognized certification body, or have been labeled “certified organic” according to United States Department of Agriculture (USDA) standards. 2. Third-party certification by recognized authorities may also be obtained at the discretion of the optional premises cultivation operation or medical marijuana center. B. Organic – Records to be kept. 1. Records of all growth media and additives used on a particular medical marijuana crop being labeled as “organic” must be maintained for inspection, and must include, but is not limited to: a. identifying information on soils, solutions and additives; b. a listing of any herbicides or pesticides used; and c. batch number(s) for the medical marijuana crop produced. 43.3-xxx Soil Fertility and Crop Nutrition. A. Fertilizers, growth media or hydroponic solutions. 1. This rule applies to cultivation of all medical marijuana crops whether designated as organic, non-organic or without designation of organic or nonorganic. 2. All nutrients and additives shall be applied in accordance with the Materials Safety Data Sheet published by the manufacturer. It is recommended that if protective clothing or equipment is required for application, such items be provided by the licensee to any and all persons applying such nutrients and/or additives. 3. The use of hydroponic solutions known to contain heavy metal contaminants that are above known safe limits shall be prohibited. B. Records to be kept.

20

1. Optional premises cultivation operations shall maintain accurate records of all fertilizers, growth media or hydroponic solutions used in the production of medical marijuana crops, including but not limited to: a. unique identifiers for each product used; b. batch or crop identifying number(s); and c. to whom the medical marijuana product was dispensed or sold. 43.3-xxx Pest, weed, and disease management. A. Prevention of contamination of medical marijuana crops by insects, fungi or other pests shall be the primary means of pest control. If a crop becomes infested with an insect or other biological pest, such as fungus or mold, appropriate treatment of the infestation should be undertaken to prevent infested medical marijuana from reaching a patient. Such treatment may include the following pesticides and herbicides deemed safe by the United States Environmental Protection Agency for use on crops intended for human consumption: (Insert list). B. Medical marijuana crops evidencing mold, powdery mildew or other fungal infestations may be treated with accepted herbicides that are listed in subsection (A) above before plants enter the flowering stage. Plants evidencing obvious infestation with fungi, molds or powdery mildew during flowering shall be removed from the growing environment and destroyed. The growing environment, including appliances, pots, tools and other items used in cultivation, shall be thoroughly cleaned according to standard horticultural practice (if there is an authority which sets a minimum standard to be followed, it should be cited here). 1. If the licensee can establish convincing evidence that certain extraction methods will remove all spores or other products of powdery mildew infestation, infested crops might be useable for extraction and refinement into topically applied medical marijuana products, but shall not be allowed to be sold as smokeable, inhaled or ingested infused products. C. The following pesticides and herbicides which have been banned by the United States Environmental Protection Agency and other federal and state agriculture authorities shall not be used in the cultivation of marijuana for medical purposes: (insert list).

21

D. The following pesticides and herbicides which are restricted for use by the United States Environmental Protection Agency and other federal and state agriculture authorities shall be used only in compliance with such restriction: (insert list). E. Treatment of any infestation shall avoid the use of any banned control products, while all other products, including restricted products, may be used only according to safe-use guidelines in the Materials Safety Data Sheet published by the manufacturer. F. Biological pest control methods shall be allowed in accordance with accepted integrated pest management protocols (if there is an authority which sets a minimum standard to be followed, it should be cited here). G. Thorough cleaning of the growing environment and all equipment shall be undertaken between crops pursuant to standard horticultural practice (if there is an authority which sets a minimum standard to be followed, it should be cited here). 43.3-xxx Inspection and Testing of Crops to Ensure Compliance. A. Spot samples may be obtained by inspectors for the state licensing authority to be used for laboratory analysis to ensure compliance with regulations governing the safe use of pesticides, herbicides and fertility and nutritional additives. 1. Visual examination for the presence of mold or mildew may be undertaken by inspectors for the state licensing authority. If contamination is found, the crop or product may be seized and destroyed. 43.3-xxx Noncompliance. A. Violation of rules set forth in this chapter can result in disciplinary action. B. Violation of rules prohibiting infested plant material from being made available to patients shall result in disciplinary action, including but not limited to monetary fines, closure of any optional premises cultivation operation or medical marijuana center for defined period of time, or other sanctions as may be appropriate. 43.3-xxx Waste Disposal. A. Hydroponic solutions.

22

Hydroponic solutions used in the cultivation of medical marijuana shall be disposed of in accordance with Materials Safety Data Sheets published by the manufacturer of hydroponic solutions and in compliance with local water district regulations. B. Soils. Used or depleted soils shall be disposed of in accordance with standard horticultural practices (if there is an authority which sets a minimum standard to be followed, it should be cited here). It is recommended that appropriate protective clothing or other equipment including face masks or respiratory protective gear be provided by the licensee to any persons conducting disposal of used or depleted soils, to prevent inhalation of or contact with potential pathogens that might be present in the soils. Soils may be disposed of by composting or other standard or conventional waste disposal procedures, or may be reutilized after appropriate treatment. C. Plant residue. CDPHE is formulating procedures for disposal and handling of plant residue. D. Records to be kept. Records on the method of disposal, date or dates of disposal, location of the disposal sites, and the types and amounts of waste disposed of shall be retained for three (3) years. With regard to the disposal of containers accumulated during disposal, the state licensing authority will consider satisfactory a statement, attested to by the licensee, describing in general terms the method and location of disposal, e.g., all containers are taken periodically to a certain site. Records of deviation from normal practice must be maintained.

23

ADMINISTRATIVE CITATIONS 43.3-xxx Applicability. This regulation provides for administrative citations which are in addition to all other legal remedies, criminal or civil, which may be pursued by the state licensing authority to address any violation of the Colorado medical marijuana laws and rules. 43.3-xxx Citation – Defined. A complete written notice, issued to a licensee by the division on an approved form and by means of which the division alleges the licensee has violated one or more Colorado medical marijuana laws or rules. 43.3-xxx Administrative Citation. A. The Director or the director’s designees may issue citations according to the Citation Violation List and Schedule of Penalties, whenever a citation is called for. The director shall have the authority to rescind any citation and cancel its associated penalty, with or without prejudice, in the event that the citation has not been issued according to the provisions of the Citation Violation List and Schedule of Penalties, or has, otherwise, been inappropriately issued. B. Each administrative citation shall contain the following information: 1. The date of the violation or, if the date of the violation is unknown, then the date the violation is identified; 2. The address or a definite description of the location where the violation occurred; 3. The section of the Colorado medical marijuana laws or rules violated and a description of the violation; 4. The amount of the fine for the violation or whether a hearing is required; 5. A description of the fine payment process, including a description of the time within which and the place to which the fine shall be paid; 6. An order prohibiting the continuation or repeated occurrence of the violation described in the administrative citation;

24

7. A description of the administrative citation review process, including the time within which the administrative citation may be contested and the place to which the request must be made; and 8. The name and signature of the citing enforcement officer. 43.3-xxx Fine and Late Payment Fee. A. Fines and any late charges due shall be made payable to ** and paid at such location or address as stated in the citation, or as may otherwise be designated by the state licensing authority. B. The due date for the state licensing authority’s receipt of a fine shall be twenty-one (21) calendar days from the date of issuance of the citation. C. Any person who fails to pay the state licensing authority any fine imposed pursuant to the provisions of this regulation on or before the date that fine is due also shall be liable for the payment of any applicable late payment charges. D. Payment of the fine shall not excuse or discharge the licensee from the duty to immediately stop violating Colorado’s medical marijuana laws or rules, nor from any other responsibility or legal consequences for a continuation or repeated occurrence(s) of a violation of Colorado’s medical marijuana laws or rules. E. Abatement of a violation shall not excuse the obligation of the licensee to pay a fine, or any late charge imposed on that untimely payment of the fine. 43.3-xxx Violation - Defined. A. For purposes of penalty assessments, a violation of Colorado medical marijuana law or rules is classified as a general violation unless otherwise specified. 1. General violation is defined as a violation which is specifically determined not to be of a serious nature, but has a relationship to Colorado’s medical marijuana laws or rules. B. A general violation can be deemed aggravated and the penalty assessment increased when any relevant circumstances, supported by evidence, are present to cause the harshest penalty allowed under Colorado law to be appropriate.

25

43.3-xxx Citation Violation List and Schedule of Penalties.

Description of Violation
Working without a license

Authority
43.3-xxx; General: 1243.3-202(2)(a) (I); Aggravated: 1243.3-901(1). 43.3-xxx; 12-43.3-202(2) (a)(I). 43.3-xxx; 12-43.3-202(2) (a)(I). 43.3-xxx; §12-43.3-202(2) (a)(I). 43.3-xxx; General: 1243.3-202(2)(a) (IX); Aggravated: 1243.3-901(3)(a). 43.3-xxx; General: 1243.3-202(2)(a) (I); Aggravated: 1243.3-901(1)(a). 43.3-xxx; 12-43.3-202(2) (a)(XI). 43.3-xxx; 12-43.3-202(2) (a)(XI). 43.3-xxx; 12-43.3-307.

1st Violation
General: $50 Aggravated: $250-$1,000 fine or Hearing $50 $50

2nd Violation
$100

3rd Violation
$200

Misuse of license Failure to have employee properly licensed Failure to have license validated/ current Failure to display license in a restricted area Licensee consuming or otherwise using medical marijuana while on duty Failure to perform proper maintenance Failure to have business facility in proper condition Exhibit behavior demonstrating unsatisfactory

$100 $100

$200 $200

$50

$100

$200

General: $50 Aggravated: $250-$1,000 fine or Hearing General: $100 Aggravated: $250-$1,000 fine or Hearing $50 $50

$100

$200

$200

Hearing

$100 $100

Hearing Hearing

$100

$200

Hearing

26

character, record or reputation Failure to keep complete set of all records necessary to show fully the business transactions of the licensee (minor) Failure to have all documentation, approvals, and variances, or copies thereof, relating to surveillance Allowing, having, or bringing unauthorized person(s) into restricted areas Failure to take all reasonable measures and precautions to establish and maintain sanitary conditions Failure to report and transmit monthly sales tax payments Incorrect or misleading informational and product displays on licensed

43.3-xxx; 12-43.3-202(2) (a)(XV).

$50

$100

$200

43.3-xxx; 12-43.3-202(2) (a)(X).

$50

$100

$200

43.3-xxx; 12-43.3-202(2) (a)(I).

$100

$200

Hearing

43.3-xxx; 12-43.3-202(2) (a)(XII).

$100

$250

Hearing

43.3-xxx; 12-43.3-202(2) (a)(XVIII). 43.3-xxx; 12-43.3-202(2) (a)(VII).

$100

$200

Hearing

$50

$100

$200

27

premises Incorrect or misleading labeling Prohibited conduct in restricted area Failure to comply with orders or rulings of state or local licensing authority Failure to follow proper regulation procedure Failure to give notification of change or loss as required by regulation Late filing or submission of any report or notification required by statute or regulation Failure to tag or label any plant or product as required by statute or regulation Failure to use scale or weight specifications as required by statute or regulation Sale of unauthorized plant materials

43.3-xx; 12-43.3-202(2) (a)(XIV). 43.3-xxx; 12-43.3-202(2) (a)(I). 43.3-xxx; 12-43.3-202(2) (a)(I).

$50 $100 $100

$100 $200 $200

$200 Hearing Hearing

43.3-xxx; 12-43.3-202(2) (a)(I). 43.3-xxx; 12-43.3-202(2) (a)(I). 43.3-xxx; 12-43.3-202(2) (a)(I).

$50

$100

Hearing

$50

$75

$100

$50

$100

Hearing

43.3-xxx; 12-43.3-202(2) (a)(I).

$200

$300

Hearing

43.3-xxx; 12-43.3-202(2) (a)(XX).

$100

$200

Hearing

43.3-xxx; 12-43.3-901.

$250-$1,000 fine or Hearing

28

or products Failure to provide safe work environment or protective gear to employees Failure of licensee to be present when required by statute or regulation Failure to or inadequate posting of public notices as required by statute or regulation Intentional disclosure of confidential information adversely affecting the public health or welfare or the safety of the immediate neighborhood in which the establishment is located Unauthorized person conducting sales or performing other business functions Obstructing or interfering with any inspections, 43.3-xxx; 12-43.3-202(2) (a)(XX). $50 $100 Hearing

43.3-xxx; 12-43.3-202(2) (a)(I).

$100

$200

Hearing

43.3-xxx; 12-43.3-202(2) (a)(I).

$50

$100

Hearing

43.3-xxx; 12-43.3-202(2) (a)(XX).

$100

$200

Hearing

43.3-xxx; 12-43.3-202(2) (a)(I).

$100

$200

Hearing

43.3-xxx; General: 1243.3-202(2)(a) (IV);

General: $100 Aggravated: $250-$1,000 fine or Hearing

$200

Hearing

29

investigations, searches or seizures conducted pursuant to statute or regulation Intimidating or threatening any officer or employee of a state or local licensing authority Engage in an unlawful, unfair or fraudulent business act or practice Possession and/or use of fraudulent identification card

Aggravated: 188-104.

43.3-xxx; General: 1243.3-202(2)(a) (XX); Aggravated: 189-111. 43.3-xxx; 12-43.3-202(2) (a)(VI). 43.3-xxx; General: 1243.3-202(2)(a) (VIII); Aggravated: 185-110.

General: $100 Aggravated: $50-$750 fine or Hearing

$200

Hearing

$100

$200

Hearing

General: $100 Aggravated: $500-$5,000 fine or Hearing

$200

Hearing

43.3-xxx Hearing Request for Administrative Citations. A. All requests made to the state licensing authority pursuant to this rule for an appeal hearing by any party aggrieved by any action, including all requests for an appeal of a citation, must be made in writing within twenty (20) days of the action appealed from unless otherwise provided by these rules. The request shall include the grounds for the appeal. If no written appeal is made within twenty (20) days, the aggrieved person shall be deemed to have waived any right to any appeal from the action. B. When a licensee appeals a citation to a Hearing Officer for a hearing, the director shall review the citation under the provisions of this rule. For any citation that the director or their designee determines should be hearing on appeal, the director shall assign the appeal according to the provisions of this rule to a hearing officer. The division shall provide notice to the licensee according to the provisions of this rule, and shall conduct the hearing pursuant to the provisions of this rule.

30

43.3-xxx Hearing Officer. The state licensing authority shall designate the hearing officer for the administrative citation hearing. 43.3-xxx Hearing Procedure For Administrative Citations. A. Provided the licensee appears for the hearing, the hearing shall be on the merits to determine whether the charged violation did occur. After the matter has been heard, the hearing officer shall make findings of fact and shall issue an order on behalf of the state licensing authority. The order of the hearing officer shall constitute an initial decision appealable to the Executive Director of the Department of Revenue under the Colorado Administrative Procedures Act. If the charged violation did occur, then the order from the hearing shall uphold the citation in full, shall not increase the penalty, shall require the fine(s) to be paid pursuant to this rule, and shall reset the payment date based upon the date of the Ruling. If the charged violation(s) did not occur, then the ruling from the hearing shall dismiss the citation with prejudice and cancel the associated penalty. B. If the licensee fails to appear for the hearing and no continuance has been granted, the hearing officer shall call the case and make a record of the proceedings, the licensee’s request for an appeal hearing shall be deemed to be abandoned, the licensee shall have waived any right to a hearing forever, the original citation shall be upheld without change, and the citation’s fines ordered to be paid pursuant to this rule, with the payment date reset based upon the date of the order. 43.3-xxx Recovery of Administrative Citation Fines and Costs. The state licensing authority may collect any past due administrative citation fine or late payment charge by use of all available legal means. The state licensing authority also may recover its collection costs as provided by law. 43.3-xxx Administrative Citations - Notices. A. Whenever a notice is required to be given under this code, unless different provisions herein are otherwise specifically made, such notice may be given either by personal delivery thereof to the person to be notified or by deposit in the United States Mail, in a sealed envelope postage prepaid, addressed to such person to be notified at his last-known business or residence address as the same appears in the public records or other records pertaining to the matter to which such notice is directed. Service by mail shall be deemed to have been completed at the time of deposit in the post office.

31

B. Failure to receive any notice specified in this regulation does not affect the validity of proceedings conducted hereunder.

32

Regulation xxxx. Storage-Warehouse Storage Permit. A. No medical marijuana shall be stored or kept in or upon any premises which shall not be duly licensed, provided however, that the state licensing authority may issue a warehouse storage permit IN ANY VENUE THAT DOES NOT IMPOSE RESTRICTIONS ON MEDICAL MARIJUANA to licensees for the storage of permitted medical marijuana in one location other than the licensed premises. B. Title to all medical marijuana stored or kept pursuant to a warehouse storage permit shall be vested in such permit holder. C. Medical marijuana may not be sold or delivered from the premises used pursuant to a warehouse storage permit. D. Any licensee obtaining a warehouse storage permit shall provide a copy of said permit to the local licensing authority and display such permit and a copy thereof, in a prominent place within their licensed premises and within the permitted storage premises. E. Any storage warehouse storing medical marijuana must meet all video and security requirements as any other licensed premises. F. Any medical marijuana stored in a storage warehouse licensed premises shall be packaged, sealed, weighed and recorded on video before it is transported directly to or from the storage warehouse directly from or to the primary licensed premises only. Any discrepancy in weight shall be documented and reported to the MMED within twenty-four (24) hours. It shall be unlawful to open a pre-sealed package of medical marijuana except upon the primary licensed premises. G. Any medical marijuana removed from a Licensee’s Optional Premises Cultivation licensed premises may only be transported directly to the Licensee’s Medical Marijuana Center or its Infused Products Manufacturer’s licensed premises on file and registered as required by law. Said marijuana shall be weighed and prepackaged on video upon the licensed premises before it is transported. All persons transporting said medical marijuana shall be licensed or registered as provided in section 12-43.3-401 C.R.S. H. No person shall transport Medical Marijuana or Medical Marijuana Infused Products pursuant to section 12-43.3 C.R.S. and these rules without first being licensed by the State Licensing Authority. I. All Medical Marijuana or Medical Marijuana Infused Products shall be packaged in a sealed package or container approved by the MMED. Each container shall be packaged and weighed prior to leaving the origination location. Each container shall be sealed by approved tamperproof tape and each tagged and labeled pursuant to the MMED’s standards.

33

J. Transportation of Medical Marijuana or Medical Marijuana Infused Products shall in all instances be accompanied by a manifest that is approved by the MMED. The manifest shall be created online and a printed copy shall be carried at all times with the products being transported. The licensee shall complete and submit a form provided by the MMED, in cases where an electronic record cannot be recorded or evidence printed. That form shall be submitted via fax prior to any transportation of Medical Marijuana or Medical Marijuana Infused Products. The manifest shall include the following: 1. Name of the licensee 2. Date completed 3. Name, location and license number of the origination location 4. Name, location and license number of the destination(s) location(s) 5. Products and quantities being delivered to each location if more than one 6. Date and approximate time of departure 7. Date and estimated time of arrival 8. Route to be traveled 9. Vehicle make and model, together with license plate number 10. Name and signature of person transporting product 11. Dated K. When determining and reporting the route to take, licensees should select the best direct route that provides efficiency and safety. When Medical Marijuana or Medical Marijuana Infused Products are transported in the manner described by the MMED through these regulations, it may be transported on any public road through any city, town, city and county or county, whether or not that city, town, city and county or county has allowed for Medical Marijuana Licensees to operate there.

34

DRAFT MEDICAL MARIJUANA WASTE DISPOSAL REGULATIONS (rec’d from Karin McGowan on 11/24/10) 1) Medical marijuana waste must be stored, secured and managed in accordance with Department of Revenue (DOR) and other applicable state statutes and regulations.

2)

Medical marijuana waste must be stored secured and managed in accordance with local and federal rules, regulations, ordinances and other requirements.

3)

Liquid waste from medical marijuana facilities shall be disposed of in compliance the applicable Water Quality Control Division statutes and regulations.

4) Medical marijuana waste must be made unusable prior to leaving a registered facility’s ( i.e. grow operation, medical marijuana dispensary, marijuana infused product supplier) secured storage and management area.

5) Medical marijuana waste shall be rendered unusable through the following methods: a) by grinding and incorporating the medical marijuana waste with nonconsumable, recyclable solid wastes listed below such that the resulting mixture is at least fifty percent non marijuana waste: i) Paper waste, ii) Plastic waste, iii) Cardboard waste, iv) Food waste,
v)

Grease or other compostable oil waste,

vi) Bokashi, or

35

vii) Other wastes approved by DOR that will render the medical marijuana waste unusable.
b)

by incorporating the medical marijuana waste with non-consumable, recyclable solid wastes listed below: i) Grease or other compostable oil waste, ii) Bokashi, or iii) Other wastes approved by DOR that will make the medical marijuana waste unusable.

6) After the medical marijuana waste is made unusable, then the solid waste shall be: i) Disposed of as a solid waste at solid waste site and disposal facility that has a Certificate of Designation from the local governing body and that is approved by DOR, ii) Deposited at a compost facility that has a Certificate of Designation from the Department of Public Health and Environment and approved by DOR, iii) Composted on-site at a facility owned by the generator and operated in compliance with the Regulations Pertaining to Solid Waste Sites and Facilities (6 CCR 1007-2, Part 1) in the Colorado Department of Public Health and Environment.

36